Target intelligence / Profile preview

Potassium Channel Subfamily K Member 9 (KCNK9)

Target
KCNK9
Molecular classification
Ion channel, Potassium channel, Two-pore domain potassium channel (K2P), K2P9.1
01

Overview

Potassium channel subfamily K member 9 (KCNK9), also known as TASK-3, is a two-pore domain potassium channel (K2P) that contributes to background or "leak" potassium currents. It stabilizes resting membrane potential and regulates cellular excitability, particularly in neurons. KCNK9 is widely expressed, especially in the brain (cerebellum), pancreas, and placenta. Mutations in KCNK9, particularly when maternally inherited due to genomic imprinting, cause KCNK9 imprinting syndrome, characterized by congenital hypotonia, feeding difficulties, intellectual disability, and delayed development. Its activity is modulated by extracellular pH, arachidonic acid, and phorbol esters.

Other names
TASK-3TASK3TWIK-related acid-sensitive K(+) channel 3Two pore potassium channel KT3.2Acid-sensitive potassium channel protein TASK‑3TASK‑3/TASK‑3TWIK-related acid-sensitive (K+) channel 3Two pore (K+) channel KT3.2
02

Mechanism of action

Not applicable; the description provided does not include any drugs that target this molecule. However, it does mention inhibition by arachidonic acid and phorbol esters, which can be explored further.

03

Biological functions

Potassium ion transmembrane transportStabilization of membrane potentialRegulation of neuronal excitabilityRegulation of synaptic transmission
04

Disease associations

Neurodevelopmental disorderKCNK9 imprinting syndrome
05

Safety considerations

Maternally inherited mutations cause KCNK9 imprinting syndromeGly236Arg mutation reduces ion flow through TASK3 channels

Beyond the preview

Go deeper on Potassium Channel Subfamily K Member 9 (KCNK9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium Channel Subfamily K Member 9 (KCNK9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call